SNNUF:OTO-Smith & Nephew Plc Ord (USD)

COMMON STOCK | Medical Devices | OTC Pink

Last Closing

USD 15.11

Change

0.00 (0.00)%

Market Cap

USD 13.38B

Volume

N/A

Analyst Target

USD 48.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Smith & Nephew PLC develops, manufactures, markets and sells medical devices. Its segments include Advanced Surgical Devices and Advanced Wound Management.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-29 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
SEMHF Siemens Healthineers AG

N/A

USD 62.09B
SMMNY Siemens Healthineers AG ADR

N/A

USD 61.88B
RYLPF Koninklijke Philips N.V

N/A

USD 28.80B
SONVF Sonova Holding AG

N/A

USD 20.54B
WILLF Demant A/S

N/A

USD 8.81B
GNGBF Getinge AB

N/A

USD 6.02B
AMBBY Ambu A/S

N/A

USD 5.26B
AMBFF Ambu A/S

N/A

USD 5.26B
GGNDF GN Store Nord A/S

N/A

USD 3.66B
GNNDY GN Store Nord A/S ADR

N/A

USD 3.45B

ETFs Containing SNNUF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange (OTC Pink)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.02% 66% D+ 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.02% 66% D+ 58% F
Trailing 12 Months  
Capital Gain 21.17% 63% D 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.17% 63% D 66% D+
Trailing 5 Years  
Capital Gain -36.51% 55% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -36.51% 55% F 44% F
Average Annual (5 Year Horizon)  
Capital Gain -9.58% N/A N/A 23% F
Dividend Return -7.54% N/A N/A 23% F
Total Return 2.04% N/A N/A 42% F
Risk Return Profile  
Volatility (Standard Deviation) 15.21% N/A N/A 92% A
Risk Adjusted Return -49.60% N/A N/A 15% F
Market Capitalization 13.38B 96% N/A 92% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector